Trial
NCT04661917
A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Bayer
Collaborators
—
Condition
Chronic Kidney Disease
Intervention
BAY2327949
Why stopped
Study withdrawn due to company decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-21